Showing results (71-80 of 102) with videos related to
Sort By:
Pageof 11
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|August 22, 2025
Impact of evolocumab on coronary physiology and microstructure in de-novo heart transplant recipientsSalma Raghad Karim, Niels Møller Jensen, Emil Nielsen Holck, et al.Health and Quality of Life Outcomes|August 19, 2020
High-intensity interval training and health-related quality of life in de novo heart transplant recipients - results from a randomized controlled trialKatrine Rolid, Arne K Andreassen, Marianne Yardley, et al.Transplant International : Official Journal of the European Society for Organ Transplantation|April 13, 2016
Long-term outcomes of thoracic transplant recipients following conversion to everolimus with reduced calcineurin inhibitor in a multicenter, open-label, randomized trialLars Gullestad, Hans Eiskjaer, Finn Gustafsson, et al.BMC Cardiovascular Disorders|April 27, 2022
Diagnosis, management, and outcome of cardiac sarcoidosis and giant cell myocarditis: a Swedish single center experienceEmanuele Bobbio, Clara Hjalmarsson, Marie Björkenstam, et al.Circulation. Heart Failure|October 26, 2018
Effect of Everolimus Initiation and Calcineurin Inhibitor Elimination on Cardiac Allograft Vasculopathy in De Novo Heart Transplant RecipientsSatish Arora, Arne K Andreassen, Kristjan Karason, et al.Cardiac Failure Review|November 27, 2019
Haemodynamic Balance in Acute and Advanced Heart Failure: An Expert Perspective on the Role of LevosimendanPiergiuseppe Agostoni, Dimitrios T Farmakis, Jose M García-Pinilla, et al.International Journal of Surgery (London, England)|June 19, 2024
Mortality in relation to diabetes remission in Swedish Obese Subjects - a prospective cohort studyLena M S Carlsson, Björn Carlsson, Peter Jacobson, et al.European Journal of Heart Failure|February 27, 2020
Randomized trial of a left ventricular assist device as destination therapy versus guideline-directed medical therapy in patients with advanced heart failure. Rationale and design of the SWEdish evaluation of left Ventricular Assist Device (SweVAD) trialKristjan Karason, Lars H Lund, Magnus Dalén, et al.Diabetes, Obesity & Metabolism|October 22, 2024
Association between delay in diabetes development and mortality in people with obesity: Up to 33 years follow-up of the prospective Swedish Obese Subjects studyLena M S Carlsson, Björn Carlsson, Peter Jacobson, et al.International Journal of Obesity (2005)|July 12, 2023
Life expectancy after bariatric surgery or usual care in patients with or without baseline type 2 diabetes in Swedish Obese SubjectsLena M S Carlsson, Björn Carlsson, Peter Jacobson, et al.Pageof 11